Ben Kiefel – PhD
October 27, 2024
- Graeme is an experienced Director, Chairman and CEO with a strong history in the capital markets industry
- Skilled in Financial Risk Management (Chairman of Audit & Risk Committee), Investment Funds and managing Life Science companies
- Listed five companies on the ASX while at Wilson HTM and raised approximately $750M in primary and secondary offerings
- Experience in companies developing analgesics, monoclonal antibodies, wound healing systems, cardiac assist devices, sterilization, disinfection and anaesthesia
